{"gene":"TNKS","run_date":"2026-04-28T21:42:59","timeline":{"discoveries":[{"year":1998,"finding":"Tankyrase (TNKS) was identified as a poly(ADP-ribose) polymerase (PARP) that localizes to human telomeres and binds TRF1, a negative regulator of telomere length. Recombinant tankyrase showed PARP activity in vitro, ADP-ribosylating both TRF1 and itself; ADP-ribosylation of TRF1 diminished its ability to bind telomeric DNA.","method":"In vitro PARP assay, immunofluorescence, yeast two-hybrid/Co-IP for TRF1 interaction","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — original discovery with in vitro reconstitution of enzymatic activity and functional consequence on TRF1-DNA binding","pmids":["9822378"],"is_preprint":false},{"year":1999,"finding":"Tankyrase localizes in a cell-cycle-dependent manner: during interphase it co-localizes with TRF1 at telomeres and also at nuclear pore complexes; at mitosis, it relocates to pericentriolar matrix of centrosomes. Telomeric localization of exogenous tankyrase required co-expression with TRF1.","method":"Indirect immunofluorescence, subcellular fractionation, immunoelectron microscopy, co-transfection experiments","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal localization methods with functional link to TRF1 dependence","pmids":["10523501"],"is_preprint":false},{"year":2000,"finding":"Tankyrase is a peripheral membrane protein associated with the Golgi and co-localizes with GLUT4 storage vesicles in adipocytes. Tankyrase binds specifically to IRAP (insulin-responsive aminopeptidase) via its ankyrin repeats interacting with the IRAP cytosolic sequence RQSPDG. Tankyrase is a novel MAPK substrate; insulin stimulation leads to its stoichiometric phosphorylation, which enhances its PARP activity.","method":"Subcellular fractionation, immunofluorescence, binding assay (ankyrin repeat domain with IRAP peptide), in vitro PARP assay, MAPK phosphorylation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including in vitro assay, co-localization, and defined binding domain","pmids":["10988299"],"is_preprint":false},{"year":2002,"finding":"Tankyrase 2 (TNKS2) is a bona fide PARP that poly(ADP-ribosyl)ates itself and TRF1 in vitro. Overexpression of TNKS2 in the nucleus releases endogenous TRF1 from telomeres, establishing a telomeric role for TNKS2 parallel to TNKS1. Tankyrase 1-mediated telomere elongation requires PARP catalytic activity and depends on telomerase.","method":"In vitro PARP assay, nuclear overexpression with immunofluorescence readout, telomere length analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro enzymatic reconstitution and cell-based functional validation with catalytic mutant","pmids":["11739745"],"is_preprint":false},{"year":2003,"finding":"ADP-ribosylation of TRF1 by tankyrase 1 releases TRF1 from telomeres, after which TRF1 is ubiquitinated and degraded by the proteasome. Only telomere-unbound TRF1 is ubiquitinated, establishing a sequential post-translational modification mechanism (ADP-ribosylation then ubiquitination) governing telomerase access.","method":"Cell-based assays, ubiquitination assays, proteasome inhibitor experiments, immunofluorescence","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — clear sequential PTM mechanism with functional readout, multiple methods","pmids":["12782650"],"is_preprint":false},{"year":2003,"finding":"TRF1 complex interacts with POT1 (protection of telomeres 1), a single-stranded telomeric DNA-binding protein, transmitting telomere-length information to the terminus where telomerase is regulated; tankyrase 1 is established as part of the TRF1 complex mediating this control.","method":"Co-immunoprecipitation, dominant-negative POT1 overexpression, telomere length analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, functional epistasis with defined phenotype","pmids":["12768206"],"is_preprint":false},{"year":2003,"finding":"FBP17 (formin-binding protein 17) binds tankyrase via a specific TNKS-binding motif (TBM), as demonstrated by yeast two-hybrid and co-immunoprecipitation of endogenous proteins in 293T cells.","method":"Yeast two-hybrid, co-immunoprecipitation of endogenous proteins","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP of endogenous proteins; functional consequence not fully defined","pmids":["14596906"],"is_preprint":false},{"year":2004,"finding":"Knockdown of tankyrase 1 caused mitotic arrest: chromosomes aligned normally but sister chromatids could not segregate, remaining associated at telomeres through proteinaceous bridges, while centromere and arm cohesion was resolved. This established a tankyrase 1-dependent pathway specifically required for sister telomere resolution before anaphase.","method":"RNAi knockdown, immunofluorescence, mitotic analysis","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — clean KD with precise mechanistic cellular phenotype, replicated in multiple experiments","pmids":["15064417"],"is_preprint":false},{"year":2006,"finding":"The HIF asparaginyl hydroxylase FIH hydroxylates specific asparagine residues within ankyrin repeat domains (ARDs) of multiple proteins; tankyrase's ankyrin repeat domain is implicated as a potential substrate within this broad ARD hydroxylation mechanism.","method":"In vitro hydroxylation assay, mass spectrometry identification of hydroxylation sites","journal":"PNAS","confidence":"Low","confidence_rationale":"Tier 3 — TNKS ARD mentioned as part of broad family screen; direct hydroxylation of TNKS not specifically validated","pmids":["17003112"],"is_preprint":false},{"year":2009,"finding":"A chemical genetic screen identified XAV939, which inhibits beta-catenin-mediated transcription by stabilizing axin. Quantitative chemical proteomics revealed that XAV939 acts by inhibiting tankyrase 1 and tankyrase 2. Both tankyrase isoforms interact with a conserved domain of axin and stimulate its degradation through the ubiquitin-proteasome pathway.","method":"Chemical genetic screen, quantitative chemical proteomics, biochemical PARP inhibition assay, axin stability assay, ubiquitin-proteasome pathway experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — foundational study with multiple orthogonal methods; 1738 citations","pmids":["19759537"],"is_preprint":false},{"year":2011,"finding":"RNF146, a RING-domain E3 ubiquitin ligase, directly interacts with poly(ADP-ribose) through its WWE domain and promotes degradation of PARsylated proteins including axin. RNF146 acts downstream of tankyrase-dependent PARsylation to couple axin PARsylation to ubiquitylation and proteasomal degradation; BLZF1 and CASC3 were identified as further substrates targeted by tankyrase and RNF146.","method":"Proteomics, RNAi screen, Co-IP, in vitro binding assay (WWE domain + PAR), ubiquitination assay, Wnt reporter assay","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods, in vitro domain binding, functional proteomics; independently replicated","pmids":["21478859"],"is_preprint":false},{"year":2011,"finding":"RNF146 forms a protein complex with tankyrase and axin; RNF146 mediates ubiquitylation of TNKS1, TNKS2, and axin for proteasomal degradation. Tankyrase auto-PARsylation and PARsylation of axin leads to RNF146-mediated ubiquitination and degradation. RNF146 also prevents tankyrase protein aggregation at centrosomes.","method":"RNAi screen, Co-IP, ubiquitination assay, Wnt reporter assay, immunofluorescence","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, functional ubiquitination assay, corroborates Nature Cell Biology findings","pmids":["21799911"],"is_preprint":false},{"year":2011,"finding":"Tankyrase regulates the adaptor protein 3BP2 stability through ADP-ribosylation followed by RNF146-mediated ubiquitylation in osteoclasts. Cherubism mutations in 3BP2 (within RSPPDG sequence) uncouple 3BP2 from tankyrase-mediated destruction, causing its stabilization and hyperactivation of SRC, SYK, and VAV signaling pathways.","method":"Mouse model, Co-IP, in vitro ADP-ribosylation assay, ubiquitination assay, signaling pathway analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro enzymatic assay, mouse model, multiple pathways validated","pmids":["22153076"],"is_preprint":false},{"year":2011,"finding":"PARP3 stabilizes the mitotic spindle and regulates tankyrase 1, associating with it as part of mitotic spindle regulation.","method":"Loss-of-function models, immunofluorescence, Co-IP","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 2 — functional association shown but TNKS role is secondary finding in a PARP3-focused study","pmids":["21270334"],"is_preprint":false},{"year":2012,"finding":"Axin forms a ternary complex with tankyrase 2 (TNKS2) and the kinesin motor KIF3A that is required for insulin-stimulated GLUT4 translocation to the plasma membrane. Insulin treatment suppresses TNKS ADP-ribosylase activity, reducing ADP-ribosylation and ubiquitination of Axin and TNKS and stabilizing the complex. Akt inhibition abrogates this complex stabilization. TNKS2-knockout mice show reduced insulin sensitivity and elevated blood glucose.","method":"Co-IP, knockdown of individual components, TNKS2 knockout mice, GLUT4 translocation assay, ADP-ribosylation assay, Akt inhibitor","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, KO mouse model, clear mechanistic pathway placement","pmids":["22473005"],"is_preprint":false},{"year":2014,"finding":"RNF146 directly interacts with tankyrase (TNKS) and disruption of the RNF146-TNKS interaction inhibits turnover of axin in cells, indicating that both PARylation of substrate (by TNKS) and PARdU (by RNF146) occur within the same protein complex. Iso-ADP-ribose binds between the WWE and RING domains of RNF146 causing allosteric activation.","method":"Structural biology (crystallography), in vitro binding, cell-based axin turnover assay, mutagenesis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional mutagenesis and cell-based validation; identifies TNKS-RNF146 complex","pmids":["25327252"],"is_preprint":false},{"year":2014,"finding":"Family-wide PARP activity analysis confirmed that tankyrase 1 and tankyrase 2 generate poly(ADP-ribose) (PAR), placing them among the minority of PARP family members capable of PAR synthesis (most generate only mono-ADP-ribose).","method":"In vitro PARP activity assay with purified recombinant proteins, mass spectrometry identification of modification type","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — direct enzymatic reconstitution across the full PARP family with mass spectrometry validation","pmids":["25043379"],"is_preprint":false},{"year":2020,"finding":"TNKS-2 poly(ADP-ribosyl)ates VEGF in the Golgi as part of a two-step process: PARP-16 in the ER catalyzes priming mono-ADP-ribosylation of VEGF, which is a prerequisite for subsequent poly-ADP-ribosylation of VEGF by TNKS-2 in the Golgi, reducing VEGF biological activity.","method":"Co-immunoprecipitation, in vitro ADP-ribosylation assay, VEGF activity assay","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic dissection of two-step modification, but single lab study","pmids":["32472322"],"is_preprint":false},{"year":2022,"finding":"USP25 deubiquitinates TNKS1, negatively regulating its ubiquitination level; USP25 overexpression stabilizes TNKS1 and activates Wnt/β-catenin signaling, while USP25 knockdown increases TNKS1 ubiquitination and reduces pathway activity in glioma cells.","method":"Co-immunoprecipitation, ubiquitination assay, Western blot, knockdown/overexpression","journal":"Disease markers","confidence":"Medium","confidence_rationale":"Tier 2-3 — Co-IP with ubiquitination assay; single lab","pmids":["35450028"],"is_preprint":false},{"year":2023,"finding":"UAT-B, a neoantimycin analog, inhibits the TNKS-USP25 protein-protein interaction, leading to decreased TNKS levels and activation of Wnt/β-catenin pathway suppression; disruption of the TNKS-USP25 complex (rather than inhibiting TNKS enzymatic activity) is sufficient to promote TNKS degradation and block CRC growth.","method":"PPI inhibition assay, Western blot, in vitro and in vivo tumor models, patient-derived xenografts","journal":"Acta pharmaceutica Sinica. B","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional PPI disruption with in vivo validation; single lab","pmids":["38261825"],"is_preprint":false},{"year":2024,"finding":"TNKS and TNKS2 bind the peroxisomal membrane protein PEX14 and promote PARsylation of proteins at the peroxisome membrane, where RNF146 regulates peroxisome import efficiency. Loss of peroxisomes increases TNKS/2 and RNF146-dependent degradation of AXIN1, sufficient to alter β-catenin transcriptional amplitude.","method":"Genome-wide CRISPRi screen, peroxisome import assay, Co-IP, Western blot, reporter assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — genome-wide unbiased screen with mechanistic follow-up and multiple orthogonal methods","pmids":["38967608"],"is_preprint":false},{"year":2024,"finding":"Upon induction of necroptosis, PARP5A (TNKS) and RNF146 form liquid-like condensates by multivalent interactions (recruited by TAX1BP1) and perform PARylation and PARylation-dependent ubiquitination (PARdU) of kinase-activated RIPK1, predominantly on K376, promoting its proteasomal degradation and restraining necroptosis.","method":"Phase separation assay, Co-IP, in vitro PARylation and ubiquitination assay, site-directed mutagenesis (K376), mouse embryonic fibroblast necroptosis model","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution of PARdU with site-specific mutagenesis and cell-based validation","pmids":["38272024"],"is_preprint":false},{"year":2025,"finding":"Catalytic inhibition of TNKS prevents TNKS turnover, causing TNKS accumulation in the β-catenin destruction complex (DC), where TNKS scaffolding function induces AXIN puncta formation, rigidifies the DC, and impedes β-catenin turnover. Chemically induced degradation of TNKS (rather than catalytic inhibition) avoids puncta formation, stabilizes AXIN without this barrier, and provides deeper WNT pathway suppression.","method":"Chemical TNKS degrader vs. inhibitor comparison, AXIN puncta imaging, β-catenin turnover assay, colorectal cancer organoid/cell proliferation assay","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic distinction between scaffolding and catalytic functions with functional readouts; preprint only","pmids":[],"is_preprint":true},{"year":2025,"finding":"In skeletal muscle cells, an Akt-Axin1/TNKS-Tiam1-Rac1 signaling axis mediates insulin-stimulated GLUT4 translocation. Insulin up-regulates Axin1 and TNKS protein levels in an Akt-dependent manner; Axin1 interacts with TNKS (interaction enhanced by insulin); TNKS enzymatic inhibition (XAV939) or Axin1 overexpression enhances GLUT4 translocation via Tiam1 upregulation and Rac1-PAK signaling, independently of Akt-AS160.","method":"Knockdown and overexpression, Co-IP, GLUT4myc translocation assay, PAK phosphorylation assay, XAV939 treatment in C2C12 myotubes","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple complementary approaches; single lab, extends earlier findings to skeletal muscle","pmids":["41207648"],"is_preprint":false},{"year":2025,"finding":"TNKS1 directly interacts with SLC7A11 (xCT) as shown by Co-IP; TNKS1 upregulation triggers ferroptosis in human aortic smooth muscle cells (elevated iron, ROS, lipid peroxidation), driving phenotypic switching from contractile to synthetic phenotype, contributing to aortic dissection pathogenesis.","method":"Co-IP (TNKS1–SLC7A11 interaction), Western blot, immunofluorescence, ferroptosis marker assays, scratch-wound assay, in vivo aortic dissection model","journal":"International immunopharmacology","confidence":"Low","confidence_rationale":"Tier 3 — single Co-IP for binding; ferroptosis link is phenotypic with limited mechanistic depth","pmids":["40359887"],"is_preprint":false}],"current_model":"TNKS (Tankyrase 1/2) is a poly(ADP-ribose) polymerase (PARP) that PARsylates substrates including TRF1 (releasing it from telomeres to allow telomerase access), axin (targeting it for RNF146-mediated ubiquitination and proteasomal degradation to activate Wnt/β-catenin signaling), 3BP2 (whose escape from TNKS-mediated destruction causes cherubism), IRAP (at Golgi/GLUT4 vesicles), RIPK1 (restraining necroptosis via phase-separated condensates with RNF146), and VEGF; TNKS also exerts a scaffolding function within the β-catenin destruction complex that is mechanistically distinct from its catalytic activity, and it participates in an Akt-Axin1/TNKS-Tiam1-Rac1 axis for insulin-stimulated GLUT4 translocation in muscle, as well as regulating peroxisome import via PARsylation at the peroxisomal membrane."},"narrative":{"teleology":[{"year":1998,"claim":"The discovery that tankyrase is a telomere-associated PARP that ADP-ribosylates TRF1, reducing its DNA-binding capacity, established TNKS as the first enzyme directly linking ADP-ribosylation to telomere-length regulation.","evidence":"Yeast two-hybrid, Co-IP, and in vitro PARP assay with recombinant tankyrase and TRF1","pmids":["9822378"],"confidence":"High","gaps":["Identity of the E3 ligase mediating TRF1 degradation was unknown","In vivo telomere elongation requirement for TNKS catalytic activity was not tested","Endogenous regulation of TNKS PARP activity remained undefined"]},{"year":2000,"claim":"Demonstrating that tankyrase localizes to Golgi/GLUT4 vesicles, binds IRAP via its ankyrin repeats, and is activated by MAPK-dependent phosphorylation expanded its functional scope beyond telomeres to insulin-responsive vesicle trafficking.","evidence":"Subcellular fractionation, immunofluorescence, IRAP peptide-binding assay, and in vitro MAPK phosphorylation/PARP activity assay in adipocytes","pmids":["10988299"],"confidence":"High","gaps":["Whether TNKS PARP activity toward IRAP has a functional consequence on GLUT4 translocation was not tested","The downstream signaling cascade linking TNKS to glucose uptake was uncharacterized"]},{"year":2002,"claim":"Establishing that both TNKS1 and TNKS2 are bona fide PARPs capable of releasing TRF1 from telomeres, and that telomere elongation requires both TNKS catalytic activity and telomerase, placed tankyrase-mediated PARsylation upstream of telomerase access in the telomere-lengthening pathway.","evidence":"In vitro PARP assay with catalytic mutants, nuclear overexpression, and telomere length analysis","pmids":["11739745"],"confidence":"High","gaps":["Relative contributions of TNKS1 versus TNKS2 at telomeres were unclear","Whether TNKS functions redundantly or cooperatively with TNKS2 in vivo was untested"]},{"year":2003,"claim":"Discovery that TRF1 ADP-ribosylation by tankyrase leads to sequential ubiquitination and proteasomal degradation of TRF1 — and separately that tankyrase 1 knockdown causes mitotic arrest through persistent sister-telomere cohesion — defined two distinct cell-cycle functions: licensing telomerase access in S phase and resolving telomeric cohesion for anaphase.","evidence":"Ubiquitination assays with proteasome inhibitors, immunofluorescence of TRF1 release; RNAi of TNKS1 with mitotic chromosome analysis","pmids":["12782650","15064417","12768206"],"confidence":"High","gaps":["The E3 ubiquitin ligase targeting PARsylated TRF1 was still unknown","Mechanism by which TNKS resolves telomeric cohesion (PARsylation of cohesion factors?) was unidentified"]},{"year":2009,"claim":"Identification of tankyrase as the direct target of the Wnt pathway inhibitor XAV939 — and demonstration that TNKS PARsylates axin to promote its ubiquitin-dependent degradation — fundamentally recast tankyrase as a central Wnt signaling regulator beyond its telomeric role.","evidence":"Chemical genetic screen, quantitative chemical proteomics, PARP inhibition assay, axin stability and Wnt reporter assays","pmids":["19759537"],"confidence":"High","gaps":["The E3 ligase coupling axin PARsylation to ubiquitination was not identified","Whether TNKS scaffolding contributes independently of catalysis was unknown"]},{"year":2011,"claim":"Identification of RNF146 as the PAR-directed E3 ligase that recognizes tankyrase-generated poly(ADP-ribose) via its WWE domain, ubiquitinating both axin and tankyrase itself, unified the PARsylation-dependent ubiquitination (PARdU) mechanism and extended it to the disease substrate 3BP2, whose escape from this pathway causes cherubism.","evidence":"Proteomics/RNAi screens, in vitro WWE–PAR binding, ubiquitination assays, Wnt reporters, mouse cherubism model with 3BP2 TBM mutations","pmids":["21478859","21799911","22153076"],"confidence":"High","gaps":["Full substrate repertoire of the TNKS–RNF146 PARdU axis was incomplete","Structural basis of allosteric RNF146 activation by PAR was unresolved"]},{"year":2012,"claim":"Demonstration that axin, TNKS2, and KIF3A form an insulin-regulated ternary complex required for GLUT4 translocation — and that TNKS2 knockout mice exhibit impaired insulin sensitivity — placed tankyrase within an Akt-dependent insulin-signaling pathway controlling glucose homeostasis.","evidence":"Co-IP, TNKS2 knockout mice with metabolic phenotyping, GLUT4 translocation and ADP-ribosylation assays, Akt inhibitor experiments","pmids":["22473005"],"confidence":"High","gaps":["Whether TNKS1 compensates for TNKS2 in GLUT4 regulation was not addressed","The precise PARsylation substrate(s) mediating vesicle transport were not defined"]},{"year":2014,"claim":"Crystal structures of the RNF146–tankyrase complex revealed that iso-ADP-ribose binding allosterically activates RNF146 and that PARdU occurs within a preformed TNKS–RNF146 complex, providing the structural basis of coupled PARsylation-ubiquitination.","evidence":"X-ray crystallography, mutagenesis, cell-based axin turnover assay","pmids":["25327252"],"confidence":"High","gaps":["How substrate specificity is determined within the TNKS–RNF146 complex was unclear","Whether other PAR-binding E3 ligases substitute for RNF146 on specific substrates was unknown"]},{"year":2022,"claim":"Discovery that USP25 deubiquitinates TNKS1 to stabilize it, and that disrupting the TNKS–USP25 interaction pharmacologically (UAT-B) promotes TNKS degradation and suppresses Wnt signaling, identified a druggable regulatory axis controlling tankyrase protein levels independently of catalytic inhibition.","evidence":"Co-IP, ubiquitination assays, USP25 knockdown/overexpression in glioma cells; PPI inhibitor UAT-B with in vivo CRC xenograft models","pmids":["35450028","38261825"],"confidence":"Medium","gaps":["USP25–TNKS interaction validated in limited cell types","Whether USP25 regulates TNKS2 equally is untested","Structural basis of the TNKS–USP25 interface is unknown"]},{"year":2024,"claim":"Two studies expanded TNKS substrates and contexts: TNKS binds PEX14 at peroxisomes to regulate peroxisome import via PARsylation, linking peroxisome loss to enhanced axin degradation and Wnt activation; separately, TNKS and RNF146 form phase-separated condensates (recruited by TAX1BP1) that PARsylate and ubiquitinate RIPK1-K376 to restrain necroptosis.","evidence":"Genome-wide CRISPRi screen with peroxisome import assays; in vitro phase-separation/PARdU reconstitution with K376 mutagenesis and MEF necroptosis model","pmids":["38967608","38272024"],"confidence":"High","gaps":["Full set of peroxisomal TNKS PARsylation substrates unknown","Whether TNKS condensate formation occurs in vivo during necroptosis awaits confirmation","Quantitative contribution of TNKS-RIPK1 axis relative to other RIPK1 regulatory mechanisms is unclear"]},{"year":2025,"claim":"Comparison of TNKS catalytic inhibitors versus chemically induced TNKS degraders revealed that TNKS possesses a scaffolding function within the β-catenin destruction complex — inhibitor-stabilized TNKS induces axin puncta and rigidifies the complex, paradoxically impeding β-catenin turnover — establishing that removing TNKS protein provides deeper Wnt suppression than catalytic inhibition alone.","evidence":"(Preprint) TNKS degrader vs. inhibitor imaging, β-catenin turnover assay, CRC organoid proliferation","pmids":[],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed","Structural basis of TNKS scaffolding within the destruction complex is undefined","In vivo therapeutic window for TNKS degraders versus inhibitors not established"]},{"year":null,"claim":"Key open questions include the full substrate repertoire of the TNKS–RNF146 PARdU axis, the structural determinants of substrate selectivity within the tankyrase ankyrin-repeat cage, the physiological relevance of TNKS phase separation beyond necroptosis, and whether TNKS1 and TNKS2 are functionally redundant or have pathway-specific roles in vivo.","evidence":"","pmids":[],"confidence":"High","gaps":["No comprehensive in vivo substrate catalog exists","TNKS1/TNKS2 double-knockout phenotype in adult tissues is incompletely characterized","Whether PAR chain length determines substrate fate (degradation vs. signaling) is unclear"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,3,4,9,10,12,16,17,21]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,3,16]}],"localization":[{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[0,1,7]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[2,17]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[1,11]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[2]},{"term_id":"GO:0005777","term_label":"peroxisome","supporting_discovery_ids":[20]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[21]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,10,11,14,15,18,19,22,23]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1,7,13]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[4,10,11,12,15,21]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[21]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[12]}],"complexes":["β-catenin destruction complex","TNKS–RNF146 PARdU complex","Shelterin-associated TRF1 complex"],"partners":["TRF1","AXIN1","RNF146","IRAP","3BP2","USP25","PEX14","RIPK1"],"other_free_text":[]},"mechanistic_narrative":"TNKS (tankyrase-1) is a poly(ADP-ribose) polymerase that PARsylates diverse substrates to couple ADP-ribosylation with RNF146-mediated ubiquitination and proteasomal degradation, thereby controlling telomere maintenance, Wnt/β-catenin signaling, mitotic progression, insulin-stimulated GLUT4 trafficking, peroxisome import, and necroptosis. At telomeres, TNKS PARsylates TRF1, releasing it from telomeric DNA and licensing its ubiquitin-dependent degradation, which permits telomerase-dependent telomere elongation; during mitosis, TNKS is required for resolution of sister-telomere cohesion [PMID:9822378, PMID:12782650, PMID:15064417]. In the Wnt pathway, TNKS PARsylates axin, promoting its RNF146-dependent ubiquitination and degradation to relieve β-catenin destruction-complex activity; TNKS additionally exerts a scaffolding function within this complex that is mechanistically separable from its catalytic role [PMID:19759537, PMID:21478859, PMID:25327252]. Cherubism-causing mutations in 3BP2 abolish the TNKS-binding motif required for tankyrase-mediated 3BP2 destruction, establishing a direct genetic link between escape from TNKS-dependent PARdU and this Mendelian bone disorder [PMID:22153076]."},"prefetch_data":{"uniprot":{"accession":"O95271","full_name":"Poly [ADP-ribose] polymerase tankyrase-1","aliases":["ADP-ribosyltransferase diphtheria toxin-like 5","ARTD5","Poly [ADP-ribose] polymerase 5A","Protein poly-ADP-ribosyltransferase tankyrase-1","TNKS-1","TRF1-interacting ankyrin-related ADP-ribose polymerase","Tankyrase I","Tankyrase-1","TANK1"],"length_aa":1327,"mass_kda":142.0,"function":"Poly-ADP-ribosyltransferase involved in various processes such as Wnt signaling pathway, telomere length and vesicle trafficking (PubMed:10988299, PubMed:11739745, PubMed:16076287, PubMed:19759537, PubMed:21478859, PubMed:22864114, PubMed:23622245, PubMed:25043379, PubMed:28619731). Acts as an activator of the Wnt signaling pathway by mediating poly-ADP-ribosylation (PARsylation) of AXIN1 and AXIN2, 2 key components of the beta-catenin destruction complex: poly-ADP-ribosylated target proteins are recognized by RNF146, which mediates their ubiquitination and subsequent degradation (PubMed:19759537, PubMed:21478859). Also mediates PARsylation of BLZF1 and CASC3, followed by recruitment of RNF146 and subsequent ubiquitination (PubMed:21478859). Mediates PARsylation of TERF1, thereby contributing to the regulation of telomere length (PubMed:11739745). Involved in centrosome maturation during prometaphase by mediating PARsylation of HEPACAM2/MIKI (PubMed:22864114). May also regulate vesicle trafficking and modulate the subcellular distribution of SLC2A4/GLUT4-vesicles (PubMed:10988299). May be involved in spindle pole assembly through PARsylation of NUMA1 (PubMed:16076287). Stimulates 26S proteasome activity (PubMed:23622245)","subcellular_location":"Cytoplasm; Golgi apparatus membrane; Cytoplasm, cytoskeleton, microtubule organizing center, centrosome; Nucleus, nuclear pore complex; Chromosome, telomere; Cytoplasm, cytoskeleton, spindle pole","url":"https://www.uniprot.org/uniprotkb/O95271/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TNKS","classification":"Not Classified","n_dependent_lines":18,"n_total_lines":1208,"dependency_fraction":0.014900662251655629},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TNKS","total_profiled":1310},"omim":[{"mim_id":"621422","title":"TELOMERASE RNA COMPONENT-INTERACTING RNase; TRIR","url":"https://www.omim.org/entry/621422"},{"mim_id":"620871","title":"DNA DAMAGE-INDUCIBLE 1 HOMOLOG 2; DDI2","url":"https://www.omim.org/entry/620871"},{"mim_id":"620652","title":"SH3 DOMAIN-BINDING PROTEIN 5-LIKE; SH3BP5L","url":"https://www.omim.org/entry/620652"},{"mim_id":"612137","title":"RING FINGER PROTEIN 146; RNF146","url":"https://www.omim.org/entry/612137"},{"mim_id":"607128","title":"TANKYRASE 2; TNKS2","url":"https://www.omim.org/entry/607128"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nuclear membrane","reliability":"Additional"},{"location":"Nuclear bodies","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TNKS"},"hgnc":{"alias_symbol":["TIN1","TINF1","TNKS1","PARP-5a","PARP5A","pART5","ARTD5"],"prev_symbol":[]},"alphafold":{"accession":"O95271","domains":[{"cath_id":"1.25.40.20","chopping":"183-332","consensus_level":"high","plddt":94.8545,"start":183,"end":332},{"cath_id":"1.25.40.20","chopping":"335-461","consensus_level":"medium","plddt":95.8862,"start":335,"end":461},{"cath_id":"1.25.40.20","chopping":"648-800","consensus_level":"medium","plddt":93.7561,"start":648,"end":800},{"cath_id":"1.10.150.50","chopping":"1032-1086","consensus_level":"high","plddt":83.8513,"start":1032,"end":1086},{"cath_id":"3.90.228.10","chopping":"1116-1312","consensus_level":"high","plddt":69.4271,"start":1116,"end":1312}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O95271","model_url":"https://alphafold.ebi.ac.uk/files/AF-O95271-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O95271-F1-predicted_aligned_error_v6.png","plddt_mean":75.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TNKS","jax_strain_url":"https://www.jax.org/strain/search?query=TNKS"},"sequence":{"accession":"O95271","fasta_url":"https://rest.uniprot.org/uniprotkb/O95271.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O95271/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O95271"}},"corpus_meta":[{"pmid":"22473005","id":"PMC_22473005","title":"The Axin/TNKS complex interacts with KIF3A and is required for insulin-stimulated GLUT4 translocation.","date":"2012","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/22473005","citation_count":70,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32393760","id":"PMC_32393760","title":"circ5615 functions as a ceRNA to promote colorectal cancer progression by upregulating TNKS.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32393760","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31811145","id":"PMC_31811145","title":"The tin1 gene retains the function of promoting tillering in maize.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31811145","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10753188","id":"PMC_10753188","title":"Upregulation of telomerase activity by X-irradiation in mouse leukaemia cells is independent of Tert, Terc, Tnks and Myc transcription.","date":"2000","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/10753188","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38272024","id":"PMC_38272024","title":"PARP5A and RNF146 phase separation restrains RIPK1-dependent necroptosis.","date":"2024","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/38272024","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22154485","id":"PMC_22154485","title":"Expression of TNKS1 is correlated with pathologic grade and Wnt/β-catenin pathway in human astrocytomas.","date":"2011","source":"Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia","url":"https://pubmed.ncbi.nlm.nih.gov/22154485","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36923920","id":"PMC_36923920","title":"Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer.","date":"2023","source":"ACS medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/36923920","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24291818","id":"PMC_24291818","title":"Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions.","date":"2014","source":"Molecular bioSystems","url":"https://pubmed.ncbi.nlm.nih.gov/24291818","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34457043","id":"PMC_34457043","title":"Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34457043","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14596906","id":"PMC_14596906","title":"The formin-binding protein 17, FBP17, binds via a TNKS binding motif to tankyrase, a protein involved in telomere maintenance.","date":"2003","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/14596906","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35504210","id":"PMC_35504210","title":"Rational design, synthesis and biological evaluation of dual PARP-1/2 and TNKS1/2 inhibitors for cancer therapy.","date":"2022","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35504210","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30717152","id":"PMC_30717152","title":"MEK Inhibition Induces Canonical WNT Signaling through YAP in KRAS Mutated HCT-15 Cells, and a Cancer Preventive FOXO3/FOXM1 Ratio in Combination with TNKS Inhibition.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/30717152","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38261825","id":"PMC_38261825","title":"A novel TNKS/USP25 inhibitor blocks the Wnt pathway to overcome multi-drug resistance in TNKS-overexpressing colorectal cancer.","date":"2023","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/38261825","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31849489","id":"PMC_31849489","title":"Biological Functions of TNKS1 and Its Relationship with Wnt/β-Catenin Pathway in Astrocytoma.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31849489","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35411247","id":"PMC_35411247","title":"TNKS inhibitors potentiate proliferative inhibition of BET inhibitors via reducing β-Catenin in colorectal cancer cells.","date":"2022","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/35411247","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21782548","id":"PMC_21782548","title":"Pinworm and TNKS inhibitors, an eccentric duo to derail the oncogenic WNT pathway.","date":"2011","source":"Clinics and research in hepatology and gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/21782548","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27995250","id":"PMC_27995250","title":"Discovery of new dual binding TNKS inhibitors of Wnt signaling inhibition by pharmacophore modeling, molecular docking and bioassay.","date":"2017","source":"Molecular bioSystems","url":"https://pubmed.ncbi.nlm.nih.gov/27995250","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35450028","id":"PMC_35450028","title":"Deubiquitination of TNKS1 Regulates Wnt/β-Catenin to Affect the Expression of USP25 to Promote the Progression of Glioma.","date":"2022","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/35450028","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30261821","id":"PMC_30261821","title":"In silico studies on potential TNKS inhibitors: a combination of pharmacophore and 3D-QSAR modelling, virtual screening, molecular docking and molecular dynamics.","date":"2018","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/30261821","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38967608","id":"PMC_38967608","title":"A genome-wide screen links peroxisome regulation with Wnt signaling through RNF146 and TNKS/2.","date":"2024","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/38967608","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40359887","id":"PMC_40359887","title":"The upregulation of TNKS1 drives the phenotypic switching of vascular smooth muscle cells in aortic dissection through the activation of ferroptosis.","date":"2025","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40359887","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32472322","id":"PMC_32472322","title":"Regulation of poly ADP-ribosylation of VEGF by an interplay between PARP-16 and TNKS-2.","date":"2020","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32472322","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31275024","id":"PMC_31275024","title":"Overexpression of the endoplasmic reticulum stress-inducible gene TIN1 causes abnormal pollen surface morphology in Arabidopsis.","date":"2017","source":"Plant biotechnology (Tokyo, Japan)","url":"https://pubmed.ncbi.nlm.nih.gov/31275024","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36603485","id":"PMC_36603485","title":"Effect and interaction of TNKS genetic polymorphisms and environmental factors on telomere damage in COEs-exposure workers.","date":"2023","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/36603485","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8449042","id":"PMC_8449042","title":"T(In1;5)44H, a complex mouse chromosomal rearrangement with a phenotypic effect.","date":"1993","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8449042","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40860181","id":"PMC_40860181","title":"CREB Regulates Cisplatin Resistance by Targeting TNKS and KDM6A in NSCLC cell-Derived Tumor Spheroid.","date":"2025","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40860181","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41052900","id":"PMC_41052900","title":"The endoplasmic reticulum-associated degradation machinery selectively degrades stress-induced TIN1 during stress recovery.","date":"2025","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/41052900","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41207648","id":"PMC_41207648","title":"Akt-Axin1/TNKS-Tiam1-Rac1 mediates insulin-stimulated GLUT4 translocation in skeletal muscle cells.","date":"2025","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/41207648","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41660562","id":"PMC_41660562","title":"TNKS1 mediates the PTEN-PI3K/AKT pathway to regulate glycolysis and proliferation in gliomas.","date":"2026","source":"IBRO neuroscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/41660562","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35052822","id":"PMC_35052822","title":"Combinatorial Virtual Screening Revealed a Novel Scaffold for TNKS Inhibition to Combat Colorectal Cancer.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/35052822","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34966450","id":"PMC_34966450","title":"Erratum: Dihydroartemisinin suppresses proliferation, migration, the Wnt/β-catenin pathway and EMT via TNKS in gastric cancer.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34966450","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40699862","id":"PMC_40699862","title":"Selective Dual Inhibition of TNKS1 and CDK8 by TCS9725 Attenuates STAT1/β-Catenin/TGFβ1 Signaling in Renal Cancer.","date":"2025","source":"Current issues in molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/40699862","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41109662","id":"PMC_41109662","title":"Targeted inhibition of human Tankyrase-1 (TNKS1) by ZT-5483 exhibited anti-parasitic activity in Toxoplasma gondii: An in silico-based, high-throughput virtual screen and in vitro approach.","date":"2025","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/41109662","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.22.677768","title":"Role of tankyrase scaffolding in the β-catenin destruction complex and WNT signaling","date":"2025-09-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.22.677768","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.11.13.688191","title":"Tankyrase inhibition demonstrates anti-fibrotic effects in preclinical pulmonary fibrosis models","date":"2025-11-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.13.688191","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.03.04.641305","title":"A potent and selective TNKS2 inhibitor for tumor-selective WNT suppression","date":"2025-03-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.04.641305","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.05.12.653623","title":"VAMP5 is a novel target for selective inhibition of gliomas with high NDRG4 expression via downregulating PLK1 and beyond","date":"2025-05-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.12.653623","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.06.14.598510","title":"Proteogenomic Reprogramming to a Functional Human Totipotent Stem Cell State via a PARP-DUX4 Regulatory Axis","date":"2024-06-15","source":"bioRxiv","url":"https://doi.org/10.1101/2024.06.14.598510","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.05.08.593091","title":"Olive phenolic compounds, potent tankyrase 1 inhibitor exhibit anti colon cancer effects by blocking Wnt/β-catenin pathway","date":"2024-05-10","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.08.593091","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"19759537","id":"PMC_19759537","title":"Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.","date":"2009","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/19759537","citation_count":1738,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9822378","id":"PMC_9822378","title":"Tankyrase, a poly(ADP-ribose) polymerase at human telomeres.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9822378","citation_count":878,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12768206","id":"PMC_12768206","title":"POT1 as a terminal transducer of TRF1 telomere length control.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12768206","citation_count":550,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25043379","id":"PMC_25043379","title":"Family-wide analysis of poly(ADP-ribose) polymerase activity.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25043379","citation_count":414,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21478859","id":"PMC_21478859","title":"RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling.","date":"2011","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21478859","citation_count":371,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17043677","id":"PMC_17043677","title":"Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.","date":"2006","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17043677","citation_count":345,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11739745","id":"PMC_11739745","title":"Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11739745","citation_count":252,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17003112","id":"PMC_17003112","title":"Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH).","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17003112","citation_count":244,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10988299","id":"PMC_10988299","title":"Tankyrase is a golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10988299","citation_count":241,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20421936","id":"PMC_20421936","title":"Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups.","date":"2010","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20421936","citation_count":237,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21270334","id":"PMC_21270334","title":"Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21270334","citation_count":231,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15064417","id":"PMC_15064417","title":"Resolution of sister telomere association is required for progression through mitosis.","date":"2004","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15064417","citation_count":226,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26673895","id":"PMC_26673895","title":"A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26673895","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25327252","id":"PMC_25327252","title":"Allosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal.","date":"2014","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/25327252","citation_count":197,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32203420","id":"PMC_32203420","title":"Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32203420","citation_count":194,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11454873","id":"PMC_11454873","title":"TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11454873","citation_count":191,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12782650","id":"PMC_12782650","title":"TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres.","date":"2003","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12782650","citation_count":185,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21799911","id":"PMC_21799911","title":"Ubiquitin ligase RNF146 regulates tankyrase and Axin to promote Wnt signaling.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21799911","citation_count":183,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10523501","id":"PMC_10523501","title":"Cell cycle dependent localization of the telomeric PARP, tankyrase, to nuclear pore complexes and centrosomes.","date":"1999","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/10523501","citation_count":174,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22153076","id":"PMC_22153076","title":"Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22153076","citation_count":161,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":20773,"output_tokens":3494,"usd":0.057364},"stage2":{"model":"claude-opus-4-6","input_tokens":6903,"output_tokens":2763,"usd":0.155385},"total_usd":0.523351,"stage1_batch_id":"msgbatch_01RPbVc9PDH9zQmYK5Hs6srm","stage2_batch_id":"msgbatch_01JVbVLzeKN2yVrsGp3zC8aM","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":33753,"output_tokens":6030,"usd":0.095854},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9883,"output_tokens":3750,"usd":0.214748}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"TNKS (tankyrase) forms a ternary complex with Axin and the kinesin motor protein KIF3A on the trans-Golgi network; insulin suppresses TNKS ADP-ribosylase activity, reducing ADP-ribosylation and ubiquitination of both Axin and TNKS, stabilizing the complex and promoting GLUT4 translocation to the plasma membrane in an Akt-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, subcellular co-localization (confocal microscopy), TNKS2 knockout mice metabolic phenotyping, specific component knockdown with GLUT4 translocation assay, Akt inhibitor epistasis\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, genetic KO mouse model, multiple orthogonal methods, functional epistasis with Akt inhibitor\",\n      \"pmids\": [\"22473005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Formin-binding protein FBP17 interacts with TNKS (tankyrase) via a specific TNKS-binding motif, as demonstrated by yeast two-hybrid and co-immunoprecipitation of endogenous proteins in 293T cells.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation of endogenous proteins\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — two orthogonal methods (Y2H + Co-IP) in single study, single lab\",\n      \"pmids\": [\"14596906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TNKS1 directly interacts with β-catenin (demonstrated by co-immunoprecipitation/pull-down), and functions as a positive regulator of the Wnt/β-catenin pathway in astrocytoma cells; TNKS1 knockdown suppresses Wnt/β-catenin signaling, reduces invasion, and increases apoptosis.\",\n      \"method\": \"Co-immunoprecipitation (β-catenin antibody pull-down), TNKS1 overexpression/knockdown with viability, apoptosis, invasion assays, Western blot for pathway markers\",\n      \"journal\": \"OncoTargets and therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP plus functional KD/OE phenotype, single lab\",\n      \"pmids\": [\"31849489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"USP25, a deubiquitinase, deubiquitinates TNKS1, reducing its ubiquitination level and stabilizing TNKS1 protein; USP25 knockdown increases TNKS1 ubiquitination and decreases TNKS1 levels, suppressing Wnt/β-catenin signaling and glioma cell proliferation, migration, and invasion.\",\n      \"method\": \"Co-immunoprecipitation to assess TNKS1 ubiquitination, USP25 overexpression/knockdown, Western blot for Wnt/β-catenin pathway markers, functional cell assays (CCK-8, Transwell, wound healing)\",\n      \"journal\": \"Disease markers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP ubiquitination assay plus functional KD/OE, single lab\",\n      \"pmids\": [\"35450028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TNKS physically interacts with USP25, and disruption of the TNKS-USP25 protein-protein interaction by the small molecule UAT-B leads to decreased TNKS protein levels and suppression of the Wnt/β-catenin pathway, indicating USP25 stabilizes TNKS.\",\n      \"method\": \"Protein-protein interaction disruption assay, in vitro and in vivo (CDX and PDX xenograft, APC spontaneous CRC models) functional studies, Western blot for TNKS and Wnt pathway components\",\n      \"journal\": \"Acta pharmaceutica Sinica. B\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — PPI disruption with multiple in vivo models, single lab\",\n      \"pmids\": [\"38261825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TNKS and TNKS2 bind the peroxisomal membrane protein PEX14 and, together with the E3 ligase RNF146, regulate peroxisome protein import efficiency via PARsylation at the peroxisome membrane; loss of peroxisomes increases TNKS/2-RNF146-dependent degradation of AXIN1, sufficient to alter β-catenin transcription.\",\n      \"method\": \"Genome-wide CRISPRi screen, genetic epistasis, peroxisome import assays, identification of TNKS/2-PEX14 interaction\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide screen plus epistasis plus functional peroxisome and Wnt pathway readouts\",\n      \"pmids\": [\"38967608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Upon necroptosis induction, PARP5A (TNKS) and RNF146 are recruited by TAX1BP1 and form liquid-like condensates via multivalent interactions to perform PARylation and PARylation-dependent ubiquitination (PARdU) of activated RIPK1, predominantly at K376 of mouse RIPK1, promoting its proteasomal degradation to restrain necroptosis.\",\n      \"method\": \"Phase separation assays, co-immunoprecipitation, site-directed mutagenesis (K376 RIPK1), proteasomal degradation assay, mouse embryonic fibroblast loss-of-function studies\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1/2 — reconstitution of condensates, mutagenesis, multiple orthogonal mechanistic assays, defined substrate and residue\",\n      \"pmids\": [\"38272024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TNKS-2 (Golgi-associated) catalyzes poly-ADP-ribosylation of VEGF, but requires prior mono-ADP-ribosylation priming of VEGF by ER-associated PARP-16 as a prerequisite; this sequential interplay between PARP-16 and TNKS-2 controls VEGF biological activity.\",\n      \"method\": \"In vitro ADP-ribosylation assays with recombinant enzymes, cell-based assays in secretory pathway context\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro enzymatic assay identifying substrate and sequential mechanism, single lab\",\n      \"pmids\": [\"32472322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In skeletal muscle cells, Axin1 interacts with TNKS (interaction enhanced by insulin); insulin up-regulates Axin1 and TNKS protein levels via Akt; Axin1 regulates TNKS protein level; TNKS catalytic inhibition (XAV939) up-regulates Axin1 and enhances insulin-stimulated GLUT4 translocation through a Tiam1-Rac1 branch independently of the Akt-AS160 branch.\",\n      \"method\": \"Co-immunoprecipitation (Axin1-TNKS interaction), GLUT4myc translocation assay, XAV939 TNKS inhibition, Axin1 and Tiam1 knockdown/overexpression, PAK phosphorylation as Rac1 activity readout\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, genetic epistasis with multiple KD/OE combinations, defined pathway branch, single lab\",\n      \"pmids\": [\"41207648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TNKS1 interacts directly with SLC7A11 (system Xc- transporter) as shown by co-IP; TNKS1 overexpression triggers ferroptosis (elevated iron, ROS, lipid peroxidation) in human aortic smooth muscle cells and drives phenotypic switching from contractile to synthetic phenotype.\",\n      \"method\": \"Co-immunoprecipitation (TNKS1-SLC7A11), TNKS1 overexpression with ferroptosis marker measurement (iron content, ROS, lipid peroxidation), ferroptosis inhibitor rescue, in vivo aortic dissection model\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP plus functional overexpression/inhibitor rescue, single lab\",\n      \"pmids\": [\"40359887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Catalytic inhibition of TNKS prevents TNKS turnover and drives its accumulation in the β-catenin destruction complex (DC), where TNKS scaffolding function induces AXIN puncta formation, rigidifies the DC, and impedes β-catenin turnover; chemically induced degradation of TNKS stabilizes AXIN without puncta formation and more deeply suppresses WNT/β-catenin signaling.\",\n      \"method\": \"Chemical degradation vs. catalytic inhibition comparison, AXIN puncta imaging, β-catenin turnover assays, colorectal cancer cell proliferation assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal mechanistic assays, preprint not yet peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Loss of chromosome 8p depletes TNKS1 expression and creates tumor-specific dependency on the functionally redundant TNKS2; structure-guided drug design yielded a first-in-class TNKS2-selective inhibitor capable of driving selective WNT inhibition in TNKS1-deficient cancer models.\",\n      \"method\": \"Structure-guided drug design, cell line and organoid TNKS1-deficient models, WNT signaling reporter assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1/2 — structure-guided design with functional cellular validation, preprint not yet peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TNKS inhibitor OM-153 stabilizes the direct TNKS targets AXIN1 and AMOTL1, suppresses WNT/β-catenin and YAP signaling, and reduces pro-fibrotic ECM expression in pulmonary fibrosis models (primary fibroblasts, lung-on-a-chip, precision-cut lung slices, and bleomycin-challenged mice).\",\n      \"method\": \"TNKS inhibitor treatment with immunoblotting, RNA-seq, ELISA, immunofluorescence; multiple preclinical fibrosis models including in vivo bleomycin mouse and ex vivo patient PCLS\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vitro, in vivo and ex vivo models with defined substrate stabilization; preprint\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"TNKS (tankyrase 1/PARP5A) is a poly(ADP-ribose) polymerase that, through its PARylation activity and scaffolding function, regulates multiple cellular processes: it PARsylates AXIN to promote its ubiquitination and degradation, thereby activating WNT/β-catenin signaling; it forms a complex with Axin and KIF3A to mediate insulin-stimulated GLUT4 translocation via an Akt-dependent, Rac1-engaging pathway; it is stabilized by the deubiquitinase USP25 and interacts with USP25 to control its own protein levels; it associates with PEX14 at peroxisome membranes where it and TNKS2 regulate peroxisomal protein import via PARylation; upon necroptosis induction it forms phase-separated condensates with RNF146 and PARylates RIPK1 at K376 to promote its proteasomal degradation; and catalytic inhibition of TNKS paradoxically impedes β-catenin destruction by accumulating TNKS in the destruction complex and inducing rigid AXIN puncta, so that TNKS degradation—rather than enzymatic inhibition alone—more effectively suppresses WNT signaling.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Tankyrase (TNKS) was identified as a poly(ADP-ribose) polymerase (PARP) that localizes to human telomeres and binds TRF1, a negative regulator of telomere length. Recombinant tankyrase showed PARP activity in vitro, ADP-ribosylating both TRF1 and itself; ADP-ribosylation of TRF1 diminished its ability to bind telomeric DNA.\",\n      \"method\": \"In vitro PARP assay, immunofluorescence, yeast two-hybrid/Co-IP for TRF1 interaction\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original discovery with in vitro reconstitution of enzymatic activity and functional consequence on TRF1-DNA binding\",\n      \"pmids\": [\"9822378\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Tankyrase localizes in a cell-cycle-dependent manner: during interphase it co-localizes with TRF1 at telomeres and also at nuclear pore complexes; at mitosis, it relocates to pericentriolar matrix of centrosomes. Telomeric localization of exogenous tankyrase required co-expression with TRF1.\",\n      \"method\": \"Indirect immunofluorescence, subcellular fractionation, immunoelectron microscopy, co-transfection experiments\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal localization methods with functional link to TRF1 dependence\",\n      \"pmids\": [\"10523501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Tankyrase is a peripheral membrane protein associated with the Golgi and co-localizes with GLUT4 storage vesicles in adipocytes. Tankyrase binds specifically to IRAP (insulin-responsive aminopeptidase) via its ankyrin repeats interacting with the IRAP cytosolic sequence RQSPDG. Tankyrase is a novel MAPK substrate; insulin stimulation leads to its stoichiometric phosphorylation, which enhances its PARP activity.\",\n      \"method\": \"Subcellular fractionation, immunofluorescence, binding assay (ankyrin repeat domain with IRAP peptide), in vitro PARP assay, MAPK phosphorylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including in vitro assay, co-localization, and defined binding domain\",\n      \"pmids\": [\"10988299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Tankyrase 2 (TNKS2) is a bona fide PARP that poly(ADP-ribosyl)ates itself and TRF1 in vitro. Overexpression of TNKS2 in the nucleus releases endogenous TRF1 from telomeres, establishing a telomeric role for TNKS2 parallel to TNKS1. Tankyrase 1-mediated telomere elongation requires PARP catalytic activity and depends on telomerase.\",\n      \"method\": \"In vitro PARP assay, nuclear overexpression with immunofluorescence readout, telomere length analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro enzymatic reconstitution and cell-based functional validation with catalytic mutant\",\n      \"pmids\": [\"11739745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"ADP-ribosylation of TRF1 by tankyrase 1 releases TRF1 from telomeres, after which TRF1 is ubiquitinated and degraded by the proteasome. Only telomere-unbound TRF1 is ubiquitinated, establishing a sequential post-translational modification mechanism (ADP-ribosylation then ubiquitination) governing telomerase access.\",\n      \"method\": \"Cell-based assays, ubiquitination assays, proteasome inhibitor experiments, immunofluorescence\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clear sequential PTM mechanism with functional readout, multiple methods\",\n      \"pmids\": [\"12782650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TRF1 complex interacts with POT1 (protection of telomeres 1), a single-stranded telomeric DNA-binding protein, transmitting telomere-length information to the terminus where telomerase is regulated; tankyrase 1 is established as part of the TRF1 complex mediating this control.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative POT1 overexpression, telomere length analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, functional epistasis with defined phenotype\",\n      \"pmids\": [\"12768206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"FBP17 (formin-binding protein 17) binds tankyrase via a specific TNKS-binding motif (TBM), as demonstrated by yeast two-hybrid and co-immunoprecipitation of endogenous proteins in 293T cells.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation of endogenous proteins\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP of endogenous proteins; functional consequence not fully defined\",\n      \"pmids\": [\"14596906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Knockdown of tankyrase 1 caused mitotic arrest: chromosomes aligned normally but sister chromatids could not segregate, remaining associated at telomeres through proteinaceous bridges, while centromere and arm cohesion was resolved. This established a tankyrase 1-dependent pathway specifically required for sister telomere resolution before anaphase.\",\n      \"method\": \"RNAi knockdown, immunofluorescence, mitotic analysis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with precise mechanistic cellular phenotype, replicated in multiple experiments\",\n      \"pmids\": [\"15064417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The HIF asparaginyl hydroxylase FIH hydroxylates specific asparagine residues within ankyrin repeat domains (ARDs) of multiple proteins; tankyrase's ankyrin repeat domain is implicated as a potential substrate within this broad ARD hydroxylation mechanism.\",\n      \"method\": \"In vitro hydroxylation assay, mass spectrometry identification of hydroxylation sites\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — TNKS ARD mentioned as part of broad family screen; direct hydroxylation of TNKS not specifically validated\",\n      \"pmids\": [\"17003112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A chemical genetic screen identified XAV939, which inhibits beta-catenin-mediated transcription by stabilizing axin. Quantitative chemical proteomics revealed that XAV939 acts by inhibiting tankyrase 1 and tankyrase 2. Both tankyrase isoforms interact with a conserved domain of axin and stimulate its degradation through the ubiquitin-proteasome pathway.\",\n      \"method\": \"Chemical genetic screen, quantitative chemical proteomics, biochemical PARP inhibition assay, axin stability assay, ubiquitin-proteasome pathway experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — foundational study with multiple orthogonal methods; 1738 citations\",\n      \"pmids\": [\"19759537\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RNF146, a RING-domain E3 ubiquitin ligase, directly interacts with poly(ADP-ribose) through its WWE domain and promotes degradation of PARsylated proteins including axin. RNF146 acts downstream of tankyrase-dependent PARsylation to couple axin PARsylation to ubiquitylation and proteasomal degradation; BLZF1 and CASC3 were identified as further substrates targeted by tankyrase and RNF146.\",\n      \"method\": \"Proteomics, RNAi screen, Co-IP, in vitro binding assay (WWE domain + PAR), ubiquitination assay, Wnt reporter assay\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods, in vitro domain binding, functional proteomics; independently replicated\",\n      \"pmids\": [\"21478859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RNF146 forms a protein complex with tankyrase and axin; RNF146 mediates ubiquitylation of TNKS1, TNKS2, and axin for proteasomal degradation. Tankyrase auto-PARsylation and PARsylation of axin leads to RNF146-mediated ubiquitination and degradation. RNF146 also prevents tankyrase protein aggregation at centrosomes.\",\n      \"method\": \"RNAi screen, Co-IP, ubiquitination assay, Wnt reporter assay, immunofluorescence\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, functional ubiquitination assay, corroborates Nature Cell Biology findings\",\n      \"pmids\": [\"21799911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Tankyrase regulates the adaptor protein 3BP2 stability through ADP-ribosylation followed by RNF146-mediated ubiquitylation in osteoclasts. Cherubism mutations in 3BP2 (within RSPPDG sequence) uncouple 3BP2 from tankyrase-mediated destruction, causing its stabilization and hyperactivation of SRC, SYK, and VAV signaling pathways.\",\n      \"method\": \"Mouse model, Co-IP, in vitro ADP-ribosylation assay, ubiquitination assay, signaling pathway analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro enzymatic assay, mouse model, multiple pathways validated\",\n      \"pmids\": [\"22153076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PARP3 stabilizes the mitotic spindle and regulates tankyrase 1, associating with it as part of mitotic spindle regulation.\",\n      \"method\": \"Loss-of-function models, immunofluorescence, Co-IP\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional association shown but TNKS role is secondary finding in a PARP3-focused study\",\n      \"pmids\": [\"21270334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Axin forms a ternary complex with tankyrase 2 (TNKS2) and the kinesin motor KIF3A that is required for insulin-stimulated GLUT4 translocation to the plasma membrane. Insulin treatment suppresses TNKS ADP-ribosylase activity, reducing ADP-ribosylation and ubiquitination of Axin and TNKS and stabilizing the complex. Akt inhibition abrogates this complex stabilization. TNKS2-knockout mice show reduced insulin sensitivity and elevated blood glucose.\",\n      \"method\": \"Co-IP, knockdown of individual components, TNKS2 knockout mice, GLUT4 translocation assay, ADP-ribosylation assay, Akt inhibitor\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, KO mouse model, clear mechanistic pathway placement\",\n      \"pmids\": [\"22473005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RNF146 directly interacts with tankyrase (TNKS) and disruption of the RNF146-TNKS interaction inhibits turnover of axin in cells, indicating that both PARylation of substrate (by TNKS) and PARdU (by RNF146) occur within the same protein complex. Iso-ADP-ribose binds between the WWE and RING domains of RNF146 causing allosteric activation.\",\n      \"method\": \"Structural biology (crystallography), in vitro binding, cell-based axin turnover assay, mutagenesis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional mutagenesis and cell-based validation; identifies TNKS-RNF146 complex\",\n      \"pmids\": [\"25327252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Family-wide PARP activity analysis confirmed that tankyrase 1 and tankyrase 2 generate poly(ADP-ribose) (PAR), placing them among the minority of PARP family members capable of PAR synthesis (most generate only mono-ADP-ribose).\",\n      \"method\": \"In vitro PARP activity assay with purified recombinant proteins, mass spectrometry identification of modification type\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic reconstitution across the full PARP family with mass spectrometry validation\",\n      \"pmids\": [\"25043379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TNKS-2 poly(ADP-ribosyl)ates VEGF in the Golgi as part of a two-step process: PARP-16 in the ER catalyzes priming mono-ADP-ribosylation of VEGF, which is a prerequisite for subsequent poly-ADP-ribosylation of VEGF by TNKS-2 in the Golgi, reducing VEGF biological activity.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ADP-ribosylation assay, VEGF activity assay\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic dissection of two-step modification, but single lab study\",\n      \"pmids\": [\"32472322\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"USP25 deubiquitinates TNKS1, negatively regulating its ubiquitination level; USP25 overexpression stabilizes TNKS1 and activates Wnt/β-catenin signaling, while USP25 knockdown increases TNKS1 ubiquitination and reduces pathway activity in glioma cells.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, Western blot, knockdown/overexpression\",\n      \"journal\": \"Disease markers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — Co-IP with ubiquitination assay; single lab\",\n      \"pmids\": [\"35450028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"UAT-B, a neoantimycin analog, inhibits the TNKS-USP25 protein-protein interaction, leading to decreased TNKS levels and activation of Wnt/β-catenin pathway suppression; disruption of the TNKS-USP25 complex (rather than inhibiting TNKS enzymatic activity) is sufficient to promote TNKS degradation and block CRC growth.\",\n      \"method\": \"PPI inhibition assay, Western blot, in vitro and in vivo tumor models, patient-derived xenografts\",\n      \"journal\": \"Acta pharmaceutica Sinica. B\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional PPI disruption with in vivo validation; single lab\",\n      \"pmids\": [\"38261825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TNKS and TNKS2 bind the peroxisomal membrane protein PEX14 and promote PARsylation of proteins at the peroxisome membrane, where RNF146 regulates peroxisome import efficiency. Loss of peroxisomes increases TNKS/2 and RNF146-dependent degradation of AXIN1, sufficient to alter β-catenin transcriptional amplitude.\",\n      \"method\": \"Genome-wide CRISPRi screen, peroxisome import assay, Co-IP, Western blot, reporter assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide unbiased screen with mechanistic follow-up and multiple orthogonal methods\",\n      \"pmids\": [\"38967608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Upon induction of necroptosis, PARP5A (TNKS) and RNF146 form liquid-like condensates by multivalent interactions (recruited by TAX1BP1) and perform PARylation and PARylation-dependent ubiquitination (PARdU) of kinase-activated RIPK1, predominantly on K376, promoting its proteasomal degradation and restraining necroptosis.\",\n      \"method\": \"Phase separation assay, Co-IP, in vitro PARylation and ubiquitination assay, site-directed mutagenesis (K376), mouse embryonic fibroblast necroptosis model\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution of PARdU with site-specific mutagenesis and cell-based validation\",\n      \"pmids\": [\"38272024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Catalytic inhibition of TNKS prevents TNKS turnover, causing TNKS accumulation in the β-catenin destruction complex (DC), where TNKS scaffolding function induces AXIN puncta formation, rigidifies the DC, and impedes β-catenin turnover. Chemically induced degradation of TNKS (rather than catalytic inhibition) avoids puncta formation, stabilizes AXIN without this barrier, and provides deeper WNT pathway suppression.\",\n      \"method\": \"Chemical TNKS degrader vs. inhibitor comparison, AXIN puncta imaging, β-catenin turnover assay, colorectal cancer organoid/cell proliferation assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic distinction between scaffolding and catalytic functions with functional readouts; preprint only\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In skeletal muscle cells, an Akt-Axin1/TNKS-Tiam1-Rac1 signaling axis mediates insulin-stimulated GLUT4 translocation. Insulin up-regulates Axin1 and TNKS protein levels in an Akt-dependent manner; Axin1 interacts with TNKS (interaction enhanced by insulin); TNKS enzymatic inhibition (XAV939) or Axin1 overexpression enhances GLUT4 translocation via Tiam1 upregulation and Rac1-PAK signaling, independently of Akt-AS160.\",\n      \"method\": \"Knockdown and overexpression, Co-IP, GLUT4myc translocation assay, PAK phosphorylation assay, XAV939 treatment in C2C12 myotubes\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple complementary approaches; single lab, extends earlier findings to skeletal muscle\",\n      \"pmids\": [\"41207648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TNKS1 directly interacts with SLC7A11 (xCT) as shown by Co-IP; TNKS1 upregulation triggers ferroptosis in human aortic smooth muscle cells (elevated iron, ROS, lipid peroxidation), driving phenotypic switching from contractile to synthetic phenotype, contributing to aortic dissection pathogenesis.\",\n      \"method\": \"Co-IP (TNKS1–SLC7A11 interaction), Western blot, immunofluorescence, ferroptosis marker assays, scratch-wound assay, in vivo aortic dissection model\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP for binding; ferroptosis link is phenotypic with limited mechanistic depth\",\n      \"pmids\": [\"40359887\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TNKS (Tankyrase 1/2) is a poly(ADP-ribose) polymerase (PARP) that PARsylates substrates including TRF1 (releasing it from telomeres to allow telomerase access), axin (targeting it for RNF146-mediated ubiquitination and proteasomal degradation to activate Wnt/β-catenin signaling), 3BP2 (whose escape from TNKS-mediated destruction causes cherubism), IRAP (at Golgi/GLUT4 vesicles), RIPK1 (restraining necroptosis via phase-separated condensates with RNF146), and VEGF; TNKS also exerts a scaffolding function within the β-catenin destruction complex that is mechanistically distinct from its catalytic activity, and it participates in an Akt-Axin1/TNKS-Tiam1-Rac1 axis for insulin-stimulated GLUT4 translocation in muscle, as well as regulating peroxisome import via PARsylation at the peroxisomal membrane.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"TNKS (tankyrase 1/PARP5A) is a poly(ADP-ribose) polymerase that serves as a central signaling node by coupling its catalytic PARylation activity with a scaffolding function to regulate Wnt/β-catenin signaling, insulin-stimulated glucose uptake, peroxisome protein import, and necroptosis. TNKS PARylates AXIN to promote its RNF146-dependent ubiquitination and proteasomal degradation, thereby sustaining Wnt/β-catenin pathway activity; TNKS protein levels are themselves controlled by USP25-mediated deubiquitination [PMID:35450028, PMID:38261825]. In insulin signaling, TNKS forms a ternary complex with Axin and the kinesin KIF3A at the trans-Golgi network, and insulin-dependent suppression of TNKS catalytic activity stabilizes this complex to drive GLUT4 translocation through an Akt- and Rac1-dependent mechanism [PMID:22473005, PMID:41207648]. Upon necroptosis induction, TNKS is recruited by TAX1BP1 to form phase-separated condensates with RNF146 that PARylate RIPK1 at K376, targeting it for proteasomal degradation and restraining cell death [PMID:38272024].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of the formin-binding protein FBP17 as a TNKS interactor established that TNKS engages non-telomeric binding partners through a specific TNKS-binding motif, broadening its functional scope beyond telomere maintenance.\",\n      \"evidence\": \"Yeast two-hybrid screen and endogenous co-IP in 293T cells\",\n      \"pmids\": [\"14596906\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of FBP17–TNKS interaction undefined\", \"No demonstration of PARylation of FBP17\", \"Single-lab finding not independently replicated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Discovery that TNKS forms a ternary complex with Axin and KIF3A at the trans-Golgi network, and that insulin suppresses TNKS ADP-ribosylase activity to stabilize this complex and promote GLUT4 translocation, revealed a direct role for TNKS in metabolic signaling through Akt-dependent vesicle trafficking.\",\n      \"evidence\": \"Reciprocal co-IP, confocal co-localization, TNKS2 KO mice, Akt inhibitor epistasis, GLUT4 translocation assays\",\n      \"pmids\": [\"22473005\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact mechanism by which reduced PARylation promotes vesicle trafficking unclear\", \"Relative contributions of TNKS vs. TNKS2 in this complex not fully resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstration that TNKS1 directly interacts with β-catenin and that its knockdown suppresses Wnt signaling in astrocytoma cells reinforced TNKS as a positive regulator of the Wnt/β-catenin pathway with functional consequences for tumor cell survival.\",\n      \"evidence\": \"Co-IP/pull-down, TNKS1 overexpression/knockdown with viability and invasion assays\",\n      \"pmids\": [\"31849489\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether direct β-catenin binding is independent of Axin scaffolding not resolved\", \"Single Co-IP direction reported\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of USP25 as the deubiquitinase that stabilizes TNKS1 protein levels revealed how TNKS abundance is itself controlled, connecting upstream deubiquitination to downstream Wnt pathway output.\",\n      \"evidence\": \"Co-IP ubiquitination assay, USP25 overexpression/knockdown with Wnt pathway and cell proliferation readouts\",\n      \"pmids\": [\"35450028\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the E3 ligase counteracting USP25 on TNKS not defined\", \"Whether USP25 also regulates TNKS2 not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Pharmacological disruption of the TNKS–USP25 protein–protein interaction by UAT-B confirmed that USP25 stabilization of TNKS is druggable and sufficient to suppress Wnt signaling in vivo, validating the USP25–TNKS axis as a therapeutic target.\",\n      \"evidence\": \"PPI disruption assay, CDX/PDX xenograft and APC-mutant spontaneous CRC models\",\n      \"pmids\": [\"38261825\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Selectivity of UAT-B for TNKS–USP25 versus other USP25 substrates not fully characterized\", \"Long-term toxicity of USP25-targeted TNKS depletion unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"A genome-wide CRISPRi screen revealed that TNKS and TNKS2 bind the peroxisomal membrane protein PEX14 and, together with RNF146, regulate peroxisome protein import, establishing a non-canonical TNKS function at peroxisomes that feeds back into Wnt signaling via AXIN1 degradation.\",\n      \"evidence\": \"CRISPRi screen, genetic epistasis, peroxisome import assays, TNKS–PEX14 interaction validation\",\n      \"pmids\": [\"38967608\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific TNKS substrates at the peroxisome beyond the AXIN1 axis not identified\", \"Physiological contexts where peroxisome–Wnt crosstalk is rate-limiting unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Reconstitution of TNKS–RNF146 phase-separated condensates that PARylate RIPK1 at K376 upon necroptosis induction, recruiting TAX1BP1 for condensate formation, demonstrated that TNKS uses liquid–liquid phase separation to restrain inflammatory cell death.\",\n      \"evidence\": \"Phase separation assays, co-IP, K376 mutagenesis, proteasomal degradation assays, MEF loss-of-function\",\n      \"pmids\": [\"38272024\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TNKS condensates form at other signaling loci beyond necroptosis not tested\", \"Structural basis for multivalent condensate assembly not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Detailed epistasis in muscle cells showed that TNKS catalytic inhibition stabilizes Axin1 and enhances GLUT4 translocation through a Tiam1–Rac1 branch independent of the canonical Akt–AS160 pathway, refining the mechanistic wiring of TNKS in insulin-stimulated glucose uptake.\",\n      \"evidence\": \"Co-IP, GLUT4myc translocation assay, XAV939 inhibition, Axin1/Tiam1 knockdown and overexpression, PAK phosphorylation readout\",\n      \"pmids\": [\"41207648\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Tiam1–Rac1 branch operates in adipocytes and other insulin-responsive tissues not shown\", \"Direct PARylation of Tiam1 or Rac1 by TNKS not tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that TNKS1 interacts with the cystine transporter SLC7A11 and that TNKS1 overexpression drives ferroptosis in vascular smooth muscle cells linked TNKS to iron-dependent cell death and vascular pathology.\",\n      \"evidence\": \"Co-IP of TNKS1–SLC7A11, TNKS1 overexpression with ferroptosis markers, ferroptosis inhibitor rescue, aortic dissection model\",\n      \"pmids\": [\"40359887\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether TNKS1 PARylates SLC7A11 or acts indirectly not determined\", \"Single Co-IP direction without reciprocal validation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for TNKS condensate formation, the full substrate repertoire at peroxisomes, whether TNKS scaffolding versus catalytic functions can be therapeutically decoupled in vivo, and the physiological significance of the TNKS–SLC7A11 interaction in ferroptosis.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of full-length TNKS in a signaling complex\", \"Relative contribution of TNKS scaffolding vs. PARylation not genetically separated in vivo\", \"Comprehensive identification of all direct PARylation substrates lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 5, 6, 7]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 6, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005777\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 3, 4, 5, 8]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"complexes\": [\n      \"TNKS–Axin–KIF3A complex\",\n      \"TNKS–RNF146 condensate\",\n      \"β-catenin destruction complex\"\n    ],\n    \"partners\": [\n      \"AXIN1\",\n      \"RNF146\",\n      \"KIF3A\",\n      \"USP25\",\n      \"PEX14\",\n      \"RIPK1\",\n      \"TAX1BP1\",\n      \"SLC7A11\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"TNKS (tankyrase-1) is a poly(ADP-ribose) polymerase that PARsylates diverse substrates to couple ADP-ribosylation with RNF146-mediated ubiquitination and proteasomal degradation, thereby controlling telomere maintenance, Wnt/β-catenin signaling, mitotic progression, insulin-stimulated GLUT4 trafficking, peroxisome import, and necroptosis. At telomeres, TNKS PARsylates TRF1, releasing it from telomeric DNA and licensing its ubiquitin-dependent degradation, which permits telomerase-dependent telomere elongation; during mitosis, TNKS is required for resolution of sister-telomere cohesion [PMID:9822378, PMID:12782650, PMID:15064417]. In the Wnt pathway, TNKS PARsylates axin, promoting its RNF146-dependent ubiquitination and degradation to relieve β-catenin destruction-complex activity; TNKS additionally exerts a scaffolding function within this complex that is mechanistically separable from its catalytic role [PMID:19759537, PMID:21478859, PMID:25327252]. Cherubism-causing mutations in 3BP2 abolish the TNKS-binding motif required for tankyrase-mediated 3BP2 destruction, establishing a direct genetic link between escape from TNKS-dependent PARdU and this Mendelian bone disorder [PMID:22153076].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"The discovery that tankyrase is a telomere-associated PARP that ADP-ribosylates TRF1, reducing its DNA-binding capacity, established TNKS as the first enzyme directly linking ADP-ribosylation to telomere-length regulation.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, and in vitro PARP assay with recombinant tankyrase and TRF1\",\n      \"pmids\": [\"9822378\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the E3 ligase mediating TRF1 degradation was unknown\", \"In vivo telomere elongation requirement for TNKS catalytic activity was not tested\", \"Endogenous regulation of TNKS PARP activity remained undefined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrating that tankyrase localizes to Golgi/GLUT4 vesicles, binds IRAP via its ankyrin repeats, and is activated by MAPK-dependent phosphorylation expanded its functional scope beyond telomeres to insulin-responsive vesicle trafficking.\",\n      \"evidence\": \"Subcellular fractionation, immunofluorescence, IRAP peptide-binding assay, and in vitro MAPK phosphorylation/PARP activity assay in adipocytes\",\n      \"pmids\": [\"10988299\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TNKS PARP activity toward IRAP has a functional consequence on GLUT4 translocation was not tested\", \"The downstream signaling cascade linking TNKS to glucose uptake was uncharacterized\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing that both TNKS1 and TNKS2 are bona fide PARPs capable of releasing TRF1 from telomeres, and that telomere elongation requires both TNKS catalytic activity and telomerase, placed tankyrase-mediated PARsylation upstream of telomerase access in the telomere-lengthening pathway.\",\n      \"evidence\": \"In vitro PARP assay with catalytic mutants, nuclear overexpression, and telomere length analysis\",\n      \"pmids\": [\"11739745\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of TNKS1 versus TNKS2 at telomeres were unclear\", \"Whether TNKS functions redundantly or cooperatively with TNKS2 in vivo was untested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Discovery that TRF1 ADP-ribosylation by tankyrase leads to sequential ubiquitination and proteasomal degradation of TRF1 — and separately that tankyrase 1 knockdown causes mitotic arrest through persistent sister-telomere cohesion — defined two distinct cell-cycle functions: licensing telomerase access in S phase and resolving telomeric cohesion for anaphase.\",\n      \"evidence\": \"Ubiquitination assays with proteasome inhibitors, immunofluorescence of TRF1 release; RNAi of TNKS1 with mitotic chromosome analysis\",\n      \"pmids\": [\"12782650\", \"15064417\", \"12768206\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The E3 ubiquitin ligase targeting PARsylated TRF1 was still unknown\", \"Mechanism by which TNKS resolves telomeric cohesion (PARsylation of cohesion factors?) was unidentified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of tankyrase as the direct target of the Wnt pathway inhibitor XAV939 — and demonstration that TNKS PARsylates axin to promote its ubiquitin-dependent degradation — fundamentally recast tankyrase as a central Wnt signaling regulator beyond its telomeric role.\",\n      \"evidence\": \"Chemical genetic screen, quantitative chemical proteomics, PARP inhibition assay, axin stability and Wnt reporter assays\",\n      \"pmids\": [\"19759537\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The E3 ligase coupling axin PARsylation to ubiquitination was not identified\", \"Whether TNKS scaffolding contributes independently of catalysis was unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of RNF146 as the PAR-directed E3 ligase that recognizes tankyrase-generated poly(ADP-ribose) via its WWE domain, ubiquitinating both axin and tankyrase itself, unified the PARsylation-dependent ubiquitination (PARdU) mechanism and extended it to the disease substrate 3BP2, whose escape from this pathway causes cherubism.\",\n      \"evidence\": \"Proteomics/RNAi screens, in vitro WWE–PAR binding, ubiquitination assays, Wnt reporters, mouse cherubism model with 3BP2 TBM mutations\",\n      \"pmids\": [\"21478859\", \"21799911\", \"22153076\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full substrate repertoire of the TNKS–RNF146 PARdU axis was incomplete\", \"Structural basis of allosteric RNF146 activation by PAR was unresolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstration that axin, TNKS2, and KIF3A form an insulin-regulated ternary complex required for GLUT4 translocation — and that TNKS2 knockout mice exhibit impaired insulin sensitivity — placed tankyrase within an Akt-dependent insulin-signaling pathway controlling glucose homeostasis.\",\n      \"evidence\": \"Co-IP, TNKS2 knockout mice with metabolic phenotyping, GLUT4 translocation and ADP-ribosylation assays, Akt inhibitor experiments\",\n      \"pmids\": [\"22473005\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TNKS1 compensates for TNKS2 in GLUT4 regulation was not addressed\", \"The precise PARsylation substrate(s) mediating vesicle transport were not defined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Crystal structures of the RNF146–tankyrase complex revealed that iso-ADP-ribose binding allosterically activates RNF146 and that PARdU occurs within a preformed TNKS–RNF146 complex, providing the structural basis of coupled PARsylation-ubiquitination.\",\n      \"evidence\": \"X-ray crystallography, mutagenesis, cell-based axin turnover assay\",\n      \"pmids\": [\"25327252\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How substrate specificity is determined within the TNKS–RNF146 complex was unclear\", \"Whether other PAR-binding E3 ligases substitute for RNF146 on specific substrates was unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Discovery that USP25 deubiquitinates TNKS1 to stabilize it, and that disrupting the TNKS–USP25 interaction pharmacologically (UAT-B) promotes TNKS degradation and suppresses Wnt signaling, identified a druggable regulatory axis controlling tankyrase protein levels independently of catalytic inhibition.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, USP25 knockdown/overexpression in glioma cells; PPI inhibitor UAT-B with in vivo CRC xenograft models\",\n      \"pmids\": [\"35450028\", \"38261825\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"USP25–TNKS interaction validated in limited cell types\", \"Whether USP25 regulates TNKS2 equally is untested\", \"Structural basis of the TNKS–USP25 interface is unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Two studies expanded TNKS substrates and contexts: TNKS binds PEX14 at peroxisomes to regulate peroxisome import via PARsylation, linking peroxisome loss to enhanced axin degradation and Wnt activation; separately, TNKS and RNF146 form phase-separated condensates (recruited by TAX1BP1) that PARsylate and ubiquitinate RIPK1-K376 to restrain necroptosis.\",\n      \"evidence\": \"Genome-wide CRISPRi screen with peroxisome import assays; in vitro phase-separation/PARdU reconstitution with K376 mutagenesis and MEF necroptosis model\",\n      \"pmids\": [\"38967608\", \"38272024\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of peroxisomal TNKS PARsylation substrates unknown\", \"Whether TNKS condensate formation occurs in vivo during necroptosis awaits confirmation\", \"Quantitative contribution of TNKS-RIPK1 axis relative to other RIPK1 regulatory mechanisms is unclear\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Comparison of TNKS catalytic inhibitors versus chemically induced TNKS degraders revealed that TNKS possesses a scaffolding function within the β-catenin destruction complex — inhibitor-stabilized TNKS induces axin puncta and rigidifies the complex, paradoxically impeding β-catenin turnover — establishing that removing TNKS protein provides deeper Wnt suppression than catalytic inhibition alone.\",\n      \"evidence\": \"(Preprint) TNKS degrader vs. inhibitor imaging, β-catenin turnover assay, CRC organoid proliferation\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint not yet peer-reviewed\", \"Structural basis of TNKS scaffolding within the destruction complex is undefined\", \"In vivo therapeutic window for TNKS degraders versus inhibitors not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the full substrate repertoire of the TNKS–RNF146 PARdU axis, the structural determinants of substrate selectivity within the tankyrase ankyrin-repeat cage, the physiological relevance of TNKS phase separation beyond necroptosis, and whether TNKS1 and TNKS2 are functionally redundant or have pathway-specific roles in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No comprehensive in vivo substrate catalog exists\", \"TNKS1/TNKS2 double-knockout phenotype in adult tissues is incompletely characterized\", \"Whether PAR chain length determines substrate fate (degradation vs. signaling) is unclear\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 3, 4, 9, 10, 12, 16, 17, 21]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 3, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [0, 1, 7]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [2, 17]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [1, 11]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005777\", \"supporting_discovery_ids\": [20]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 10, 11, 14, 15, 18, 19, 22, 23]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1, 7, 13]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [4, 10, 11, 12, 15, 21]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [21]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"complexes\": [\n      \"β-catenin destruction complex\",\n      \"TNKS–RNF146 PARdU complex\",\n      \"Shelterin-associated TRF1 complex\"\n    ],\n    \"partners\": [\n      \"TRF1\",\n      \"AXIN1\",\n      \"RNF146\",\n      \"IRAP\",\n      \"3BP2\",\n      \"USP25\",\n      \"PEX14\",\n      \"RIPK1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}